Related Experiment Video
Updated: Jun 16, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Citrus consumption and cancer incidence: the Ohsaki cohort study
Wen-Qing Li1, Shinichi Kuriyama, Qiang Li
1Division of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan. vincentlee820313@yahoo.com
Abstract:
Basic research and case-control studies have suggested that citrus consumption may protect against cancer. However, the protective effect has been observed from few prospective studies. This study investigated the association of citrus consumption with cancer incidence among 42,470 Japanese adults in the Ohsaki National Health Insurance Cohort, which covered an age range of 40-79 years, and was followed up from 1995 to 2003 for all-cancer and individual cancer incidence. Citrus consumption was assessed using a self-administered questionnaire. The Cox proportional hazard model was applied to estimate relative risks (RRs) and 95% CIs. During the 323,204 person-years of follow-up, 3,398 cases were identified totally. Citrus consumption, especially daily consumption, was correlated with reduced all-cancer incidence, the RRs were 0.89 (95% CI = 0.80-0.98) for total participants, 0.86 (0.76-0.98) for males and 0.93 (0.79-1.09) for females, as well as multiple cancers at individual sites, especially pancreatic (RR = 0.62, 95% CI = 0.38-1.00) and prostate cancer (RR = 0.63, 95% CI = 0.41-0.97). Joint effect analysis showed a reduced risk of overall cancer existed only for subjects who consumed >or=1 cup green tea/day (RR = 0.83, 95% CI = 0.73-0.93) as well as for males (RR = 0.83, 95% CI = 0.71-0.97) or females (RR = 0.82, 95% CI = 0.68-0.99). These findings suggest that citrus consumption is associated with reduced all-cancer incidence, especially for subjects having simultaneously high green tea consumption. Further work on the specific citrus constituents is warranted, and clinical trials are ultimately necessary to confirm the protective effect.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Cancer Survival Analysis
Bias in Epidemiological Studies
Chi-square Analysis
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
